AtaiBeckley (ATAI) Exchange Rate Effect (2020 - 2026)
AtaiBeckley (ATAI) recorded quarterly Exchange Rate Effect of -$276000.0 in Q1 2026, down 962.5% quarter-over-quarter from $32000.0 in Q1 2025, and down 962.5% on a YoY basis from $32000.0 in Q1 2025.
AtaiBeckley (ATAI) Exchange Rate Effect (2020 - 2026) Analysis & Trends
AtaiBeckley has disclosed Exchange Rate Effect across 6 years of filings, most recently posting -$468000.0 for Q3 2025.
- Exchange Rate Effect for Q3 2025 came in at -$468000.0, down 297.47% year-over-year; the trailing twelve-month figure through Sep 2025 was -$107000.0 (down 496.3% YoY), and the FY2024 annual result was $362000.0, up 91.53% from the prior year.
- Exchange Rate Effect was -$276000.0 for Q1 2026 at AtaiBeckley, down from $32000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $32000.0 in Q1 2025 to a low of -$276000.0 in Q1 2026.
- The 5-year median for Exchange Rate Effect is $66000.0 (2024), against an average of -$59052.6.
- Across the five-year window, Exchange Rate Effect plunged 3141.18% in 2022 and surged 212.12% in 2025, its largest moves.
- AtaiBeckley's Exchange Rate Effect stood at -$17000.0 in 2021, then plunged by 3141.18% to -$551000.0 in 2022, then jumped by 61.52% to -$212000.0 in 2023, then soared by 158.02% to $123000.0 in 2024, then tumbled by 480.49% to -$468000.0 in 2025.
- The last three Exchange Rate Effect figures came in at -$468000.0 (Q3 2025), $206000.0 (Q2 2025), and $32000.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 8.68 Mn |
| 10 | AtaiBeckley | 1.45 Bn | 1.45 Bn | - | -276,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -276,000.00 |
| Mar 31, 2026 | -276,000.00 |
| Sep 30, 2025 | -468,000.00 |
| Sep 30, 2025 | -468,000.00 |
| Jun 30, 2025 | 206,000.00 |
| Jun 30, 2025 | 206,000.00 |
| Mar 31, 2025 | 32,000.00 |
| Mar 31, 2025 | 32,000.00 |
| Mar 31, 2025 | 32,000.00 |
| Mar 31, 2025 | 32,000.00 |
| Dec 31, 2024 | 123,000.00 |
| Dec 31, 2024 | 123,000.00 |
| Sep 30, 2024 | 237,000.00 |
| Sep 30, 2024 | 237,000.00 |
| Jun 30, 2024 | 66,000.00 |
| Jun 30, 2024 | 66,000.00 |
| Mar 31, 2024 | -64,000.00 |
| Mar 31, 2024 | -64,000.00 |
| Dec 31, 2023 | -212,000.00 |
| Dec 31, 2023 | -212,000.00 |